Skip to main content
Fig. 7 | Journal of Biomedical Science

Fig. 7

From: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models

Fig. 7

Neither elastase nor cathepsin G mediated cleavage of the soluble urokinase-type plasminogen activator (uPA) receptor (suPAR) in a focal segmental glomerulosclerosis (FSGS) mouse model. Plasma activities of elastase (a) and cathepsin G (b) were determined in the wild-type (WT) and uPA−/− groups during the course of the experiment until 4 weeks after Adriamycin treatment. # p < 0.05 vs. week 0 (W0); *p < 0.05 vs. the WT

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127